AstraZeneca Market Cap

AstraZeneca has a market cap or net worth of $240.81 billion as of August 13, 2025. Its market cap has decreased by -0.58% in one year.

Market Cap

240.81B

Enterprise Value

266.48B

1-Year Change

-0.58%

Ranking

n/a

Market Cap Chart

Since November 21, 2000, AstraZeneca's market cap has increased from $63.18B to $240.81B, an increase of 281.16%. That is a compound annual growth rate of 5.56%.

Market Cap History

Date	Market Cap	% Change
Aug 12, 2025	233.55B	14.99%
Dec 31, 2024	203.11B	-2.65%
Dec 29, 2023	208.65B	-0.60%
Dec 30, 2022	209.91B	20.44%
Dec 31, 2021	174.28B	32.86%
Dec 31, 2020	131.17B	1.42%
Dec 31, 2019	129.34B	34.47%
Dec 31, 2018	96.18B	9.54%
Dec 29, 2017	87.81B	27.12%
Dec 30, 2016	69.07B	-19.47%
Dec 31, 2015	85.77B	-3.07%
Dec 31, 2014	88.48B	19.53%
Dec 31, 2013	74.02B	21.17%
Dec 31, 2012	61.09B	-6.34%
Dec 30, 2011	65.22B	-2.68%
Dec 31, 2010	67.02B	-1.37%
Dec 31, 2009	67.95B	13.67%
Dec 31, 2008	59.78B	-7.97%
Dec 31, 2007	64.96B	-23.07%
Dec 29, 2006	84.44B	6.23%
Dec 30, 2005	79.49B	29.74%
Dec 31, 2004	61.26B	-26.15%
Dec 31, 2003	82.95B	37.87%
Dec 31, 2002	60.17B	-10.20%
Dec 29, 2000	67.00B	6.05%

View and export this data all the way back to 2000. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	574.04B
Johnson & Johnson	416.11B
AbbVie	350.91B
UnitedHealth Group	236.90B
Novartis AG	230.64B
Abbott Laboratories	228.03B
Novo Nordisk	223.00B
Merck & Co.	200.57B

Market Cap Rankings